Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$7.99 – $12.60
37% from low
No one on the platform currently holds FGEN.
No tracked institution reports a position in FGEN as of their last filing.
| Execution date | Ratio |
|---|---|
| 2025-06-17 | 1-for-25reverse |
No one on the platform has traded FGEN yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $6M | -7.1% | $-11.95 | $-17.39–$-6.51 | — | 2 |
| 2027 | $6M | +0.0% | $-14.65 | $-20.14–$-9.16 | — | 2 |
| 2028 | $6M | +1.3% | $-8.41 | $-8.59–$-8.23 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 4 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2025-11-10 | $-4.01 | $-1.61 | +59.9% |
| 2025-08-11 | $-2.25 | $-3.38 | -50.2% |
| 2025-05-12 | $0.75 | $-4.00 | -633.3% |
| 2025-03-17 | $-0.08 | $-0.08 | +0.0% |
| 2024-11-12 | $-0.38 | $-0.17 | +55.3% |
| 2024-08-06 | $-0.26 | $-0.16 | +38.5% |
| 2024-05-06 | $-0.31 | $-0.33 | -6.5% |
| 2024-02-26 | $-0.42 | $-0.57 | -35.7% |
| $54M |
| — |
| MRSNMersana Therapeutics, Inc. | $29.08 | +0.00% | $145M | — |
| OKUROnKure Therapeutics, Inc. | $3.90 | -0.76% | $158M | — |
Source: Financial Modeling Prep · peers by sector/industry